ACG-FOS Demonstration Project

Medical Necessity Documentation Toolset

Narcotic Analgesic Combinations

The drug combination morphine/naltrexone (trade name Embeda) was an opioid combination pain medication developed by King Pharmaceuticals for use in moderate to severe pain.[1] The active ingredients were morphine sulfate and naltrexone hydrochloride; morphine being an opioid receptor agonist and naltrexone an opioid receptor antagonist. It is a schedule 2 controlled substance, and was intended for long-term pain caused by malignancy or where lower tiers of the pain management ladder have already been exhausted, and where medications such as oxycodone would otherwise have been indicated... Wikipedia

 

 

Manufacturer's Website: Embeda                                                                                                                                         Average retail cost: $202/month

Xartemis XR is a controlled release oral combination of acetominophen and oxycodone for the treatment of acute pain.... Wikipedia

 

 

Manufacturer's Website: Xartemis                                                                                                                                        Average retail cost: $288/month